Life science current events reported by MedCity News this week.
See the TEDMED talks (as cartoon illustrations). In the “social spaces” tent, many of the event sponsors and other companies are coming up with unique approaches to the vendor booth. Booz Allen Hamilton hired an artist to do illustrations of each TEDMED talk and puts them up all around their booth.
Biotechnology company acquires license for Alzheimer’s disease vaccine. Nuron Biotech in Exton, Pennsylvania licensed the vaccine from Texas biotechnology company Vitruvian BioMedical. Under the terms of the exclusive worldwide license, Nuron will be responsible for development and commercialization. The financial terms of the deal were not disclosed. The company is expected to advance the vaccine to the clinical stage next year.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
St. Jude Medical pulls Medtronic into the fray in battle against cardiologist. St. Jude Medical, which has been battling negative publicity about its faulty Riata ICD leads, most recently from Minneapolis cardiologist Robert Hauser, displayed some raw nerves pulling its crosstown rival Medtronic into the fray.
GSK’s deal with Japanese biotech aims to find new cancer treatments. GSK’s agreement with Tokyo-based Chiome Bioscience calls for the companies to first conduct a pilot study using Chiome’s proprietary technology. Chiome’s proprietary platform technology can generate antibodies. Under the agreement, GSK and Chiome will generate monoclonal antibodies, antibodies that can seek out and recognize cancers anywhere in the body. Depending on how the pilot goes, GSK has the option to pursue further development.
Is crowdfunding a viable option for medical technology startups? The answer is a resounding “maybe.”
